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Figure 1: Cartoon of a phospho-protein. For an accurate analysis of the phosphorylation stoichiometry, complementary 
quantitation of the unmodified counterpart of the phosphopeptide and protein expression is essential. 
Despite the transient and dynamic character of the protein phosphorylation, current 
mass spectrometry-based methods are capable to identify thousands of phosphorylation 
sites. However, the ionization and fragmentation difficulties of phosphopeptides, 
together with enrichment strategies, applied in most phosphoproteomics methods, 
hamper quantitation.   
 
With this new iTRAQ-strategy, called PiTRAQ, we focus on the unphosphorylated peptide 
precursor mass and hence circumvent the common challenges in phosphopeptide 
analysis. Phosphatase dephosphorylation of one half of each sample, combined with 
iTRAQ, allows to simultaneously define phosphorylation stoichiometry and compare 
protein expression between multiple biological states in a single experiment. 
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For the PiTRAQ strategy each protein 
sample is digested and split into two 
identical parts and labeled with a 
different iTRAQ label. One half is in vitro 
dephosphorylated with phosphatases, 
the other half is not treated. The four 
parts are immediately recombined and 
prepared for LC-MSMS. The iTRAQ 
multiplex provides the opportunity to 
quantify both the phosphorylation 
stoichiometry and the expressional 
differences between multiple samples.   
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Figure 2: After in vitro dephosphorylation of one half of each sample the initially phosphorylated peptide ends up in the 
same MSMS spectrum as its unmodified equivalent. iTRAQ allows to quantify expressional differences between samples. 
Internal Standards 
Protein Level: PeppermintStick™ Phosphoprotein Molecular Weight Standard (Invitrogen) 
Mixture of two phosphorylated (CASB_Bovin, OVAL_Chick) and four non-phosphorylated 
proteins (e.g. ALBU_Bovin). 
Peptide Level: MS PhosphoMix Standards 1,2 & 3 (Sigma). 
Reagents  
iTRAQ 4plex (ABSciex). 
Phosphatases (AP): E.Coli phoshatase P4069 (Sigma), Thermosensitive Alkaline 
Phosphatase M9910 (Promega), Alkaline phosphatase M0290L (New England Biolabs) and 
9614  (Sigma). 
Samples 
Fractionation Possibilities Experiment: HepG2 cells. Forskolin-stimulated and control. 
Application of PiTRAQ: Hela cells. EGF-stimulated and control. 
LCMSMS-analysis 
Waters Q-TOF Premier TM - Dionex UltiMate™ 3000. 
AB SCIEX TripleTOF ® 5600+ - Eksigent ekspert™ nanoLC 400 System. 
Thermo Scientific Q Exactive TM (Orbitrap technology) - Dionex UltiMate™ 3000. 
Data analysis 
Raw data processed with Mascot Distiller and searched with Daemon (Matrix Sciences ™ ). 
The software  Rover (CompOmics) filters unique and deviant peptides from large data-sets. 
 
PiTRAQ on Current Mass Specs  
The principle of PiTRAQ shown on the PeppermintStick™ 
Phosphoprotein standard analyzed on a Q-TOF Premier TM. The 
Rover software is developed to filter the unique peptides from 
the dataset and to validate iTRAQ data.  The distribution of all 
annotated peptides with no serine, threonine or tyrosine is 
applied to assign the Z-score that defines the limit for 
phosphopeptide identification. 
 
Figure 3: Upper panel: On a non-phosphoprotein (e.g. ALBU_BOVIN) all peptides have a 1:1 
ratio. Lower panel: Peptides with a skewed iTRAQ ratio are phosphopeptides and have a low 
Z-score as shown for the protein CASB_Bovine who has one annotated phosphopeptide. 
In this approach peptides are only briefly separated for 
labeling and dephosphorylation, which allows for unlimited 
prefractionation and thus an in depth proteome analysis on 
previous generation mass specs. Including an SDS PAGE 
prefractionation step allows for the discovery of 
phosphorylation events on hydrophobic proteins which are 
lost in most MS-based approaches. 
 
Figure 4. Left panel: Overview of a 
PiTRAQ protocol including three 
fractionation steps. 1D SDS-PAGE of 
500µg of HepG2 lysate is followed by 
SCX (2D) and C18 (3D) LC fractionation 
of the labeled and partly 
dephosphorylated peptide mixture. 
Lower panel: Phosphopeptides from the 
12.450 annotated spectra obtained from 
analysis on the Waters Q-TOF Premier TM 
in 30 LCMSMS runs.  
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CONCLUSION: 
- Combining in vitro removal of PTMs with isobaric labeling holds 
promise in circumventing PTM quantitation by MS. 
 
- The PiTRAQ approach is capable of measuring phosphopeptide 
stoichiometry and the expressional differences between 
multiple biological states in a single experiment. 
 
- Rover is highly suitable to define the deviant peptide ratios of a 
large dataset.   
 
- PiTRAQ allows for unlimited prefractionation steps. 
 
- The iTRAQ strategie can be applied on current Q-TOF and 
Orbitrap mass spectrometers. 
 
PERSPECTIVES: 
- Validating the influence of data quality on PiTRAQ results. 
 
- Confirming the quantitative value of PiTRAQ, based on the 
PhosphoMix Standards. 
 
- Extending (phospho)peptide coverage by combining different 
fractionation steps and different mass spectrometers. 
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Combine 
The PiTRAQ protocol was applied on ± 2µg of a protein extract 
of EGF-stimulated and non-stimulated Hela cells and analyzed 
on a Q-Tof and Orbitrap mass spectrometer. The venn 
diagrams display the number of identified phosphopeptides in 
a single run. The analysis on the two different mass  
spectrometers annotated 108 common phosphopeptides for 
the control and 117 for the EGF-stimulated sample. 
Q-TOF 
TripleTOF ® 5600+ System (AB SCIEX)  
Orbitrap 
Q Exactive TM (Thermo Scientific)   
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